- Home
- RLMD vs MRAM Comparison
RLMD vs MRAM Comparison
Compare RLMD & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- MRAM
- Stock Information
- Founded
- RLMD 2004
- MRAM 2008
- Country
- RLMD United States
- MRAM United States
- Employees
- RLMD N/A
- MRAM N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- MRAM Semiconductors
- Sector
- RLMD Health Care
- MRAM Technology
- Exchange
- RLMD Nasdaq
- MRAM Nasdaq
- Market Cap
- RLMD 110.6M
- MRAM 131.1M
- IPO Year
- RLMD N/A
- MRAM 2016
- Fundamental
- Price
- RLMD $3.16
- MRAM $5.86
- Analyst Decision
- RLMD Hold
- MRAM Strong Buy
- Analyst Count
- RLMD 2
- MRAM 2
- Target Price
- RLMD $7.50
- MRAM $9.00
- AVG Volume (30 Days)
- RLMD 110.4K
- MRAM 122.6K
- Earning Date
- RLMD 11-07-2024
- MRAM 10-30-2024
- Dividend Yield
- RLMD N/A
- MRAM N/A
- EPS Growth
- RLMD N/A
- MRAM N/A
- EPS
- RLMD N/A
- MRAM 0.07
- Revenue
- RLMD N/A
- MRAM $53,865,000.00
- Revenue This Year
- RLMD N/A
- MRAM N/A
- Revenue Next Year
- RLMD N/A
- MRAM $7.15
- P/E Ratio
- RLMD N/A
- MRAM $82.17
- Revenue Growth
- RLMD N/A
- MRAM N/A
- 52 Week Low
- RLMD $1.88
- MRAM $4.89
- 52 Week High
- RLMD $7.22
- MRAM $9.44
- Technical
- Relative Strength Index (RSI)
- RLMD 39.24
- MRAM 44.06
- Support Level
- RLMD $3.06
- MRAM $5.83
- Resistance Level
- RLMD $3.43
- MRAM $6.23
- Average True Range (ATR)
- RLMD 0.20
- MRAM 0.27
- MACD
- RLMD -0.04
- MRAM -0.05
- Stochastic Oscillator
- RLMD 16.30
- MRAM 8.47
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).